N-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-2-morpholin-2-ylacetamide

C15H16Cl2N4O2 — CID 141183017

IUPACN-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-2-morpholin-2-ylacetamide
SMILESO=C(CC1CNCCO1)Nc1ccn(-c2ccc(Cl)cc2Cl)n1
InChIInChI=1S/C15H16Cl2N4O2/c16-10-1-2-13(12(17)7-10)21-5-3-14(20-21)19-15(22)8-11-9-18-4-6-23-11/h1-3,5,7,11,18H,4,6,8-9H2,(H,19,20,22)
InChIKeyJANXFUVUGDPNIN-UHFFFAOYSA-N
MW355.23 g/mol
LogP2.50
Rot. Bonds4

About N-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-2-morpholin-2-ylacetamide

N-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-2-morpholin-2-ylacetamide (PubChem CID 141183017) has the molecular formula C15H16Cl2N4O2 and a molecular weight of 355.23 g/mol. Its IUPAC name is N-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-2-morpholin-2-ylacetamide.

Molecular Properties

Compound NameN-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-2-morpholin-2-ylacetamide
PubChem CID141183017
Molecular FormulaC15H16Cl2N4O2
Molecular Weight355.23 g/mol
Exact Mass354.07
IUPAC NameN-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-2-morpholin-2-ylacetamide
SMILESO=C(CC1CNCCO1)Nc1ccn(-c2ccc(Cl)cc2Cl)n1
InChIInChI=1S/C15H16Cl2N4O2/c16-10-1-2-13(12(17)7-10)21-5-3-14(20-21)19-15(22)8-11-9-18-4-6-23-11/h1-3,5,7,11,18H,4,6,8-9H2,(H,19,20,22)
InChIKeyJANXFUVUGDPNIN-UHFFFAOYSA-N
XLogP2.50
TPSA68.18 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms23
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500355.23
LogP ≤ 52.50
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze N-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-2-morpholin-2-ylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[2-(4-chlorophenyl)pyrazol-3-yl]-3-ethoxypropanamide
CID 72118219
(2S,3S)-N-[1-(4-chlorophenyl)pyrazol-3-yl]-3-methyl-1,4-dioxane-2-carboxamide
CID 136586600
(2S)-4-[[1-(2,4-dichlorophenyl)pyrazol-3-yl]carbamoyl]morpholine-2-carboxylic acid
CID 164637700
(2R)-N-[1-(2,4-dichlorophenyl)pyrazol-3-yl]morpholine-2-carboxamide;2,2,2-trifluoroacetic acid
CID 166238518
N-(1-(3,4-dichlorophenyl)-1H-pyrazol-3-yl)-2-morpholinoacetamide
CID 24743570
2-methoxyimino-N-[2-(2,4,6-trichlorophenyl)pyrazol-3-yl]acetamide
CID 54071314
1-(2,4-dichlorophenyl)-N-[2-(2,6-dimethylmorpholin-4-yl)ethyl]pyrazol-3-amine
CID 57705415
N-[1-(3,4-dichlorophenyl)pyrazol-3-yl]-4-piperidin-1-ylbutanamide
CID 57705421
N-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-2-piperidin-1-ylacetamide
CID 57705422
N-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-2-(2,6-dimethylmorpholin-4-yl)acetamide
CID 57705430
N-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-2-(diethylamino)acetamide
CID 57705450
N-[1-(3,4-dichlorophenyl)pyrazol-3-yl]-4-(2,6-dimethylmorpholin-4-yl)butanamide
CID 57705453

Frequently Asked Questions

What is the IUPAC name of N-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-2-morpholin-2-ylacetamide?
The IUPAC name of N-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-2-morpholin-2-ylacetamide (CID 141183017) is N-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-2-morpholin-2-ylacetamide.
What is the SMILES notation for N-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-2-morpholin-2-ylacetamide?
The canonical SMILES for N-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-2-morpholin-2-ylacetamide is O=C(CC1CNCCO1)Nc1ccn(-c2ccc(Cl)cc2Cl)n1.
What is the InChIKey of N-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-2-morpholin-2-ylacetamide?
The InChIKey is JANXFUVUGDPNIN-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H16Cl2N4O2/c16-10-1-2-13(12(17)7-10)21-5-3-14(20-21)19-15(22)8-11-9-18-4-6-23-11/h1-3,5,7,11,18H,4,6,8-9H2,(H,19,20,22).
What are the key properties of N-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-2-morpholin-2-ylacetamide?
N-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-2-morpholin-2-ylacetamide has a molecular weight of 355.23 g/mol, XLogP of 2.50, 4 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-2-morpholin-2-ylacetamide is sourced from PubChem (CID 141183017), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).